Why does the media abort adult stem cell success stories?

Just days after President Obama was sworn into office, biotech company Geron received FDA permission to conduct clinical trials to see if embryonic stem cells can treat spinal-cord injuries.

The media covered this story extensively, but completely ignored an earlier announcement that American and Ecuadorian researchers have discovered a way to treat similar spinal-cord injuries using adult stem cells harvested from bone marrow.

Critics, of course, say that harvesting embryonic stem cells requires the destruction of human life.

“Geron’s future human trial made huge news,” said Wesley Smith, senior fellow at the Discovery Institute. “But a successful human treatment for the same condition has been ignored by the mainstream media. Why the news blockade? Wrong kind of stem cells, apparently.”

“This is just further evidence,” said Dawn Vargo, bioethics analyst for Focus On the Family, “that some members of the media continue to promote the agenda of embryonic stem cell research – at the cost of young human lives and at the cost, and even detriment, of helping patients.”

Is it true that numerous breakthroughs have been made with adult stem cells, and that zero breakthroughs have been made with embryonic stem cells?

The media might not want to know, but we do.

Source: CitizenLink.com